PT Hetzer Medical Indonesia Tbk Statistics
PT Hetzer Medical Indonesia Tbk (MEDS) Stock Statistics & Valuation Metrics
Total Valuation
PT Hetzer Medical Indonesia Tbk has a market cap or net worth of IDR 90.63B. The enterprise value is IDR 117.96B.
- Market Cap
- IDR 90.63B
- Enterprise Value
- IDR 117.96B
Share Statistics
PT Hetzer Medical Indonesia Tbk has 1,562,500,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,562,500,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PT Hetzer Medical Indonesia Tbk’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -14.16%.
- Return on Equity (ROE)
- -0.17
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -14.16%
- Return on Capital Employed (ROCE)
- -0.17
- Revenue Per Employee
- 414.32M
- Profits Per Employee
- -521.63M
- Employee Count
- 16
- Asset Turnover
- 0.11
- Inventory Turnover
- 0.66
Valuation Ratios
The current PE Ratio of PT Hetzer Medical Indonesia Tbk is -207.14. PT Hetzer Medical Indonesia Tbk’s PEG ratio is -0.87.
- PE Ratio
- -207.14
- PS Ratio
- 4.02
- PB Ratio
- 1.80
- Price to FCF
- -36.89
- Price to Operating Cash Flow
- 110.24
- PEG Ratio
- -0.87
Income Statement
In the last 12 months, PT Hetzer Medical Indonesia Tbk had revenue of 6.63B and earned -8.35B in profits. Earnings per share was -5.34.
- Revenue
- 6.63B
- Gross Profit
- -1.40B
- Operating Income
- -8.24B
- Pretax Income
- -8.57B
- Net Income
- -8.35B
- EBITDA
- -4.00B
- Earnings Per Share (EPS)
- -5.34
Cash Flow
In the last 12 months, operating cash flow was 822.09M and capital expenditures -3.28B, giving a free cash flow of -2.46B billion.
- Operating Cash Flow
- 822.09M
- Free Cash Flow
- -2.46B
- Free Cash Flow per Share
- -1.57
Dividends & Yields
PT Hetzer Medical Indonesia Tbk pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.71%
- Earnings Yield
- -0.48%
Stock Price Statistics
- Beta
- 0.90
- 52-Week Price Change
- -6.45%
- 50-Day Moving Average
- 74.00
- 200-Day Moving Average
- 74.96
- Relative Strength Index (RSI)
- 39.47
- Average Volume (3m)
- 93.14M
Important Dates
PT Hetzer Medical Indonesia Tbk upcoming earnings date is Mar 10, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Mar 10, 2027
- Ex-Dividend Date
- ―
Financial Position
PT Hetzer Medical Indonesia Tbk as a current ratio of 1.17, with Debt / Equity ratio of 16.56%
- Current Ratio
- 1.17
- Quick Ratio
- 0.18
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- -1.80
- Interest Coverage Ratio
- -12.25
Taxes
In the past 12 months, PT Hetzer Medical Indonesia Tbk has paid -221.90M in taxes.
- Income Tax
- -221.90M
- Effective Tax Rate
- 0.03
Enterprise Valuation
PT Hetzer Medical Indonesia Tbk EV to EBITDA ratio is 24.06, with an EV/FCF ratio of -38.47.
- EV to Sales
- 4.19
- EV to EBITDA
- 24.06
- EV to Free Cash Flow
- -38.47
- EV to Operating Cash Flow
- 114.98
Balance Sheet
PT Hetzer Medical Indonesia Tbk has IDR 1.46B in cash and marketable securities with IDR 5.36B in debt, giving a net cash position of -IDR 3.90B billion.
- Cash & Marketable Securities
- IDR 1.46B
- Total Debt
- IDR 5.36B
- Net Cash
- -IDR 3.90B
- Net Cash Per Share
- -IDR 2.50
- Tangible Book Value Per Share
- IDR 32.18
Margins
Gross margin is 27.15%, with operating margin of -2.61%, and net profit margin of -1.92%.
- Gross Margin
- 27.15%
- Operating Margin
- -2.61%
- Pretax Margin
- -1.87%
- Net Profit Margin
- -1.92%
- EBITDA Margin
- 17.41%
- EBIT Margin
- -2.61%
Analyst Forecast
The average price target for PT Hetzer Medical Indonesia Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 368.99%
- EPS Growth Forecast
- 92.49%
